» Articles » PMID: 24077364

Deep Sequencing Identifies Two Genotypes and High Viral Genetic Diversity of Human Pegivirus (GB Virus C) in Rural Ugandan Patients

Overview
Journal J Gen Virol
Specialty Microbiology
Date 2013 Oct 1
PMID 24077364
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Human pegivirus (HPgV), formerly 'GB virus C' or 'hepatitis G virus', is a member of the genus Flavivirus (Flaviviridae) that has garnered significant attention due to its inhibition of HIV, including slowing disease progression and prolonging survival in HIV-infected patients. Currently, there are six proposed HPgV genotypes that have roughly distinct geographical distributions. Genotypes 2 and 3 are the most comprehensively characterized, whereas those genotypes occurring on the African continent, where HPgV prevalence is highest, are less well studied. Using deep sequencing methods, we identified complete coding HPgV sequences in four of 28 patients (14.3%) in rural Uganda, east Africa. One of these sequences corresponds to genotype 1 and is the first complete genome of this genotype from east Africa. The remaining three sequences correspond to genotype 5, a genotype that was previously considered exclusively South African. All four positive samples were collected within a geographical area of less than 25 km(2), showing that multiple HPgV genotypes co-circulate in this area. Analysis of intra-host viral genetic diversity revealed that total single-nucleotide polymorphism frequency was approximately tenfold lower in HPgV than in hepatitis C virus. Finally, one patient was co-infected with HPgV and HIV, which, in combination with the high prevalence of HIV, suggests that this region would be a useful locale to study the interactions and co-evolution of these viruses.

Citing Articles

Clinical and molecular aspects of human pegiviruses in the interaction host and infectious agent.

Samadi M, Salimi V, Haghshenas M, Miri S, Mohebbi S, Ghaemi A Virol J. 2022; 19(1):41.

PMID: 35264187 PMC: 8905790. DOI: 10.1186/s12985-022-01769-3.


Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication.

Yu Y, Wan Z, Wang J, Yang X, Zhang C Virulence. 2022; 13(1):324-341.

PMID: 35132924 PMC: 8837232. DOI: 10.1080/21505594.2022.2029328.


Exploring the Diversity of the Human Blood Virome.

Cebria-Mendoza M, Bracho M, Arbona C, Larrea L, Diaz W, Sanjuan R Viruses. 2021; 13(11).

PMID: 34835128 PMC: 8621239. DOI: 10.3390/v13112322.


Human pegivirus 1 in Cabo Verde: prevalence and genotypic distribution among HIV-infected individuals.

de Pina-Araujo I, Horta M, Mello F, Soares C Arch Virol. 2021; 166(5):1345-1353.

PMID: 33689039 DOI: 10.1007/s00705-021-05014-0.


Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.

Zanella M, Cordey S, Kaiser L Clin Microbiol Rev. 2020; 33(4).

PMID: 32847820 PMC: 7462738. DOI: 10.1128/CMR.00027-20.


References
1.
Bhattarai N, Stapleton J . GB virus C: the good boy virus?. Trends Microbiol. 2012; 20(3):124-30. PMC: 3477489. DOI: 10.1016/j.tim.2012.01.004. View

2.
Polgreen P, Xiang J, Chang Q, Stapleton J . GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals. Microbes Infect. 2003; 5(13):1255-61. DOI: 10.1016/j.micinf.2003.08.006. View

3.
Kapoor A, Simmonds P, Scheel T, Hjelle B, Cullen J, Burbelo P . Identification of rodent homologs of hepatitis C virus and pegiviruses. mBio. 2013; 4(2):e00216-13. PMC: 3622934. DOI: 10.1128/mBio.00216-13. View

4.
Timmons C, Shao Q, Wang C, Liu L, Liu H, Dong X . GB virus type C E2 protein inhibits human immunodeficiency virus type 1 assembly through interference with HIV-1 gag plasma membrane targeting. J Infect Dis. 2013; 207(7):1171-80. PMC: 3583272. DOI: 10.1093/infdis/jit001. View

5.
Williams C, Klinzman D, Yamashita T, Xiang J, Polgreen P, Rinaldo C . Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med. 2004; 350(10):981-90. DOI: 10.1056/NEJMoa030107. View